Therefore, an increased dosage of the IFNR gene cluster is necessary for increased severity and penetrance of major traits associated with DS, further supporting the notion that T21 elicits an interferonopathy amenable to therapeutic intervention. The gene discussed is IFNAR2; the disease is Dravet syndrome.